.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Personalized Strategies for Advanced Colorectal Cancers

EP. 1: Adjuvant Therapy for Stage II and III Colon Cancer

July 10th 2019

EP. 2: Molecular Profiling in Stage II and III Colon Cancer

July 10th 2019

EP. 3: Adjuvant Treatment or "Watch and Wait" in Stage II CRC

July 10th 2019

EP. 4: IDEA Collaboration; Impact on Adjuvant Therapy

July 10th 2019

EP. 5: Changing Paradigms for Rectal Cancer

July 10th 2019

EP. 6: Molecular Testing in 2019 for mCRC

July 10th 2019

EP. 7: Frontline Therapy for mCRC

July 10th 2019

EP. 8: TRIBE-2: FOLFOX or FOLFIRI With Bevacizumab in mCRC

July 10th 2019

EP. 9: Colon Cancer in Young Patients

July 10th 2019

EP. 10: Management of Colorectal Cancer Metastases

July 10th 2019

EP. 11: Maintenance Therapy for mCRC

July 10th 2019

EP. 12: New Therapy Options for BRAF-Mutated mCRC

July 10th 2019

EP. 13: Salvage Therapy for mCRC

July 10th 2019

EP. 14: Immunotherapy in CRC

July 10th 2019

EP. 15: Future Directions in I/O Therapy for mCRC

July 10th 2019